Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema
NCT01823081Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fasudil in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Started Jan 2013; status: completed.
02
Drugs
fasudil
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01823081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01823081.